Skip to content

Evaluation of the screening for an uterine transplantation

Evaluation of the screening for an uterine transplantation - FEH_UTx

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015135
Enrollment
50
Registered
2018-07-24
Start date
2018-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N97.2

Interventions

Group 1: AUFI patients and live donors: All data relevant to the study (age, BMI, blood group, pre-existing conditions, psychological assessment, etc.) are requested as part of the clinical routine.

Sponsors

Forschungsinstitut für FrauengesundheitDepartment für Frauengesundheit
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: AUFI: - Age: 18 - 37 years - Patients with AUFI - written consent Donor: - Age: 18 - 64 years - written consent

Exclusion criteria

Exclusion criteria: - BMI> 30kg / m2 - Pre-existing malignancies in the last 5 years - missing consent

Design outcomes

Primary

MeasureTime frame
The purpose of this study is to evaluate the screening of AUFI patients and live donors, which will be screened for UTx at the Department of Women's Health, in order to develop robust criteria for the suitability for UTx. All data relevant to the study (age, BMI, blood group, pre-existing conditions, psychological assessment, etc.) are requested as part of the clinical routine. No study-specific examinations are carried out.

Secondary

MeasureTime frame
Long-term effects and outcomes of UTx to obtain a comprehensive assessment of the effectiveness and impacts of the transplantation.

Countries

Germany

Contacts

Public ContactSara Brucker

Forschungsinstitut für Frauengesundheit

sara.brucker@med.uni-tuebingen.de07071 29 82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026